Allison B Rosen1, David M Cutler. 1. Division of General Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA. abrosen@umich.edu
Abstract
BACKGROUND: Measuring spending on diseases is critical to assessing the value of medical care. OBJECTIVE: To review the current state of cost of illness estimation methods, identifying their strengths, limitations, and uses. We briefly describe the current National Health Expenditure Accounts, and then go on to discuss the addition of cost of illness estimation to the National Health Expenditure Accounts. CONCLUSION: Recommendations are made for future research aimed at identifying the best methods for developing and using disease-based national health accounts to optimize the information available to policy makers as they struggle with difficult resource allocation decisions.
BACKGROUND: Measuring spending on diseases is critical to assessing the value of medical care. OBJECTIVE: To review the current state of cost of illness estimation methods, identifying their strengths, limitations, and uses. We briefly describe the current National Health Expenditure Accounts, and then go on to discuss the addition of cost of illness estimation to the National Health Expenditure Accounts. CONCLUSION: Recommendations are made for future research aimed at identifying the best methods for developing and using disease-based national health accounts to optimize the information available to policy makers as they struggle with difficult resource allocation decisions.
Authors: K A Schulman; K R Yabroff; J Kong; K F Gold; L E Rubenstein; A J Epstein; H Glick Journal: Pharmacoepidemiol Drug Saf Date: 2001 Aug-Sep Impact factor: 2.890
Authors: Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-12-15 Impact factor: 29.690
Authors: Zoë P Mackay; Dmitry Dukhovny; Kathryn A Phillips; Alan H Beggs; Robert C Green; Richard B Parad; Kurt D Christensen Journal: Value Health Date: 2020-03-20 Impact factor: 5.725
Authors: Angela B Mariotto; K Robin Yabroff; Yongwu Shao; Eric J Feuer; Martin L Brown Journal: J Natl Cancer Inst Date: 2011-01-12 Impact factor: 13.506
Authors: Joseph L Dieleman; Ranju Baral; Maxwell Birger; Anthony L Bui; Anne Bulchis; Abigail Chapin; Hannah Hamavid; Cody Horst; Elizabeth K Johnson; Jonathan Joseph; Rouselle Lavado; Liya Lomsadze; Alex Reynolds; Ellen Squires; Madeline Campbell; Brendan DeCenso; Daniel Dicker; Abraham D Flaxman; Rose Gabert; Tina Highfill; Mohsen Naghavi; Noelle Nightingale; Tara Templin; Martin I Tobias; Theo Vos; Christopher J L Murray Journal: JAMA Date: 2016-12-27 Impact factor: 56.272
Authors: Anthony L Bui; Joseph L Dieleman; Hannah Hamavid; Maxwell Birger; Abigail Chapin; Herbert C Duber; Cody Horst; Alex Reynolds; Ellen Squires; Paul J Chung; Christopher J L Murray Journal: JAMA Pediatr Date: 2017-02-01 Impact factor: 16.193
Authors: Jennifer L Lund; K Robin Yabroff; Yoko Ibuka; Louise B Russell; Paul G Barnett; Joseph Lipscomb; William F Lawrence; Martin L Brown Journal: Med Care Date: 2009-07 Impact factor: 2.983